ArticleFrontiers in endocrinology2025
Case Report: Therapeutic potential of traditional Korean herbal medicine Jeopgol-tang in bone regeneration: a case series of delayed union over 5 months.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The delayed union of fractures poses considerable challenges in orthopedic treatment, affecting patients' quality of life and healthcare outcomes. Although various treatment options are available, their efficacy may be limited in patients with prolonged delayed union. This study investigated the therapeutic potential of Jeopgol-tang (JGT), a traditional herbal decoction, for treating cases of delayed union persisting for more than 5 months. Three patients with different fracture sites (pubic ramus, multiple metatarsals, and femoral neck) who exhibited insufficient healing after conventional treatment were administered JGT (100 mL per pack, twice daily) for 2-6 months depending on individual healing progress and fracture complexity. Radiological assessments demonstrated progressive improvement in all cases. Notably, one patient avoided reoperation after exhibiting initial signs of bone healing within 1 month of treatment, whereas all patients achieved complete union and reported improved mobility and reduced pain. These findings suggest that JGT could be an effective complementary treatment option for delayed union, particularly in cases in which conventional treatments have yielded limited success. Nevertheless, larger prospective clinical trials and mechanistic studies are required to validate these results and to explore the therapeutic mechanisms of JGT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.